Harvard Bioscience, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $34.7M | $107.4M | $4.6M |
| Jun 2017 | $33.6M | $108.9M | $4.7M |
| Sep 2017 | $33.8M | $110.7M | $5.8M |
| Dec 2017 | $28.5M | $109.4M | $5.7M |
| Mar 2018 | $91.7M | $170.9M | $6.0M |
| Jun 2018 | $88.0M | $165.1M | $5.6M |
| Sep 2018 | $84.1M | $165.0M | $6.7M |
| Dec 2018 | $85.9M | $168.6M | $8.2M |
| Mar 2019 | $91.0M | $171.3M | $5.0M |
| Jun 2019 | $85.9M | $166.2M | $4.9M |
| Sep 2019 | $85.7M | $162.8M | $6.8M |
| Dec 2019 | $83.2M | $164.9M | $8.3M |
| Mar 2020 | $80.3M | $156.3M | $5.9M |
| Jun 2020 | $74.6M | $150.7M | $2.6M |
| Sep 2020 | $72.4M | $149.6M | $2.8M |
| Dec 2020 | $79.6M | $156.3M | $8.3M |
| Mar 2021 | $74.1M | $151.2M | $5.8M |
| Jun 2021 | $75.3M | $154.0M | $6.2M |
| Sep 2021 | $77.0M | $153.9M | $5.5M |
| Dec 2021 | $78.9M | $162.3M | $7.8M |
| Mar 2022 | $81.7M | $158.0M | $5.4M |
| Jun 2022 | $77.8M | $155.3M | $4.3M |
| Sep 2022 | $75.0M | $147.0M | $5.1M |
| Dec 2022 | $73.1M | $145.4M | $4.5M |
| Mar 2023 | $71.2M | $145.6M | $3.8M |
| Jun 2023 | $67.5M | $142.9M | $4.3M |
| Sep 2023 | $65.4M | $139.7M | $5.3M |
| Dec 2023 | $64.3M | $137.4M | $4.3M |
| Mar 2024 | $64.3M | $133.2M | $4.3M |
| Jun 2024 | $61.7M | $128.9M | $4.0M |
| Sep 2024 | $65.9M | $131.2M | $4.6M |
| Dec 2024 | $63.3M | $126.6M | $4.1M |
| Mar 2025 | $65.0M | $79.8M | $5.5M |
| Jun 2025 | $64.4M | $80.1M | $7.4M |
| Sep 2025 | $63.9M | $78.0M | $6.8M |
| Dec 2025 | $66.3M | $80.1M | $8.6M |
| Mar 2026 | $67.9M | $77.9M | $7.1M |
| Jun 2026 | $68.9M | $76.3M | $6.5M |